Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia
Bone marrow fibrosis (MF) has been shown to indicate therapy failure in Ph+ chronic myeloid leukemia (CML). However, the results on the development of MF during interferon-α therapy of CML are controversial. The significance of the interferon dose has not been considered as yet. In total, 627 bone m...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
29 July 2004
|
| In: |
Leukemia
Year: 2004, Jahrgang: 18, Heft: 9, Pages: 1460-1467 |
| ISSN: | 1476-5551 |
| DOI: | 10.1038/sj.leu.2403451 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.leu.2403451 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/2403451 
|
| Verfasserangaben: | G. Buesche, M. Freund, R. Hehlmann, A. Georgii, A. Ganser, H. Hecker, H. Heimpel, C. Fonatsch, B. Heinze, M. Pfirrmann, S. Holgado, A. Schmeil, A. Tobler, J. Hasford, T. Buhr, H.-H. Kreipe and the German CML Study Group |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1801734674 | ||
| 003 | DE-627 | ||
| 005 | 20220820182915.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220513s2004 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/sj.leu.2403451 |2 doi | |
| 035 | |a (DE-627)1801734674 | ||
| 035 | |a (DE-599)KXP1801734674 | ||
| 035 | |a (OCoLC)1341459982 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Büsche, Guntram |e VerfasserIn |0 (DE-588)137485735 |0 (DE-627)592747816 |0 (DE-576)303793155 |4 aut | |
| 245 | 1 | 0 | |a Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response |b meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia |c G. Buesche, M. Freund, R. Hehlmann, A. Georgii, A. Ganser, H. Hecker, H. Heimpel, C. Fonatsch, B. Heinze, M. Pfirrmann, S. Holgado, A. Schmeil, A. Tobler, J. Hasford, T. Buhr, H.-H. Kreipe and the German CML Study Group |
| 264 | 1 | |c 29 July 2004 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.05.2022 | ||
| 520 | |a Bone marrow fibrosis (MF) has been shown to indicate therapy failure in Ph+ chronic myeloid leukemia (CML). However, the results on the development of MF during interferon-α therapy of CML are controversial. The significance of the interferon dose has not been considered as yet. In total, 627 bone marrow biopsies taken prospectively from 200 patients with CML recruited in two studies using different doses of interferon-α ± low-dose cytosine arabinoside were examined for MF before and during therapy. The results showed that the risk of MF depended significantly on the interferon-α dose applied (P<0.000005). MF progressed during low-dose therapy (3 × 5 × 106 IU/week), but was prevented from progression when applying high dose (5 × 106 IU/m2/per day). MF disappeared when high-dose interferon-α was combined with low-dose cytosine arabinoside (P<0.000005). The risk of death markedly increased when MF occurred or progressed (P<0.0009), independent of all other prognostic factors evaluated including the cytogenetic response. In conclusion, the effectiveness of interferon-α on MF depends on the treatment intensity. MF reverses when combining high-dose interferon-α with low-dose cytosine arabinoside, but progresses when applying low-dose interferon-α. MF appears to be a significant early indicator of ineffective therapy in CML. | ||
| 650 | 4 | |a Cancer Research | |
| 650 | 4 | |a general | |
| 650 | 4 | |a Hematology | |
| 650 | 4 | |a Intensive / Critical Care Medicine | |
| 650 | 4 | |a Internal Medicine | |
| 650 | 4 | |a Medicine/Public Health | |
| 650 | 4 | |a Oncology | |
| 700 | 1 | |a Freund, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hehlmann, Rüdiger |d 1941- |e VerfasserIn |0 (DE-588)1037003489 |0 (DE-627)751737879 |0 (DE-576)390939463 |4 aut | |
| 700 | 1 | |a Georgii, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ganser, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hecker, H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heimpel, H. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fonatsch, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heinze, B. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pfirrmann, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Holgado, S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schmeil, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tobler, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hasford, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Buhr, T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kreipe, H.-H. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia |d London : Springer Nature, 1997 |g 18(2004), 9, Seite 1460-1467 |h Online-Ressource |w (DE-627)32046699X |w (DE-600)2008023-2 |w (DE-576)094139733 |x 1476-5551 |7 nnas |a Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia |
| 773 | 1 | 8 | |g volume:18 |g year:2004 |g number:9 |g pages:1460-1467 |g extent:8 |a Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia |
| 856 | 4 | 0 | |u https://doi.org/10.1038/sj.leu.2403451 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/2403451 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220513 | ||
| 993 | |a Article | ||
| 994 | |a 2004 | ||
| 998 | |g 1037003489 |a Hehlmann, Rüdiger |m 1037003489:Hehlmann, Rüdiger |d 60000 |d 61200 |e 60000PH1037003489 |e 61200PH1037003489 |k 0/60000/ |k 1/60000/61200/ |p 3 | ||
| 999 | |a KXP-PPN1801734674 |e 4133946812 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["G. Buesche, M. Freund, R. Hehlmann, A. Georgii, A. Ganser, H. Hecker, H. Heimpel, C. Fonatsch, B. Heinze, M. Pfirrmann, S. Holgado, A. Schmeil, A. Tobler, J. Hasford, T. Buhr, H.-H. Kreipe and the German CML Study Group"]},"language":["eng"],"person":[{"family":"Büsche","role":"aut","display":"Büsche, Guntram","given":"Guntram"},{"given":"M.","display":"Freund, M.","family":"Freund","role":"aut"},{"given":"Rüdiger","display":"Hehlmann, Rüdiger","role":"aut","family":"Hehlmann"},{"display":"Georgii, A.","given":"A.","family":"Georgii","role":"aut"},{"role":"aut","family":"Ganser","given":"A.","display":"Ganser, A."},{"given":"H.","display":"Hecker, H.","family":"Hecker","role":"aut"},{"display":"Heimpel, H.","given":"H.","role":"aut","family":"Heimpel"},{"role":"aut","family":"Fonatsch","given":"C.","display":"Fonatsch, C."},{"family":"Heinze","role":"aut","given":"B.","display":"Heinze, B."},{"display":"Pfirrmann, M.","given":"M.","role":"aut","family":"Pfirrmann"},{"display":"Holgado, S.","given":"S.","role":"aut","family":"Holgado"},{"role":"aut","family":"Schmeil","given":"A.","display":"Schmeil, A."},{"given":"A.","display":"Tobler, A.","family":"Tobler","role":"aut"},{"family":"Hasford","role":"aut","given":"J.","display":"Hasford, J."},{"given":"T.","display":"Buhr, T.","family":"Buhr","role":"aut"},{"display":"Kreipe, H.-H.","given":"H.-H.","family":"Kreipe","role":"aut"}],"recId":"1801734674","note":["Gesehen am 13.05.2022"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response","subtitle":"meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia","title":"Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response"}],"physDesc":[{"extent":"8 S."}],"id":{"eki":["1801734674"],"doi":["10.1038/sj.leu.2403451"]},"relHost":[{"recId":"32046699X","id":{"zdb":["2008023-2"],"issn":["1476-5551"],"eki":["32046699X"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Leukemia","subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia"}],"origin":[{"publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedKey":"1997","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group"}],"part":{"volume":"18","year":"2004","text":"18(2004), 9, Seite 1460-1467","extent":"8","pages":"1460-1467","issue":"9"},"language":["eng"],"pubHistory":["Nachgewiesen 11.1997 -"],"note":["Gesehen am 15.03.04"],"disp":"Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemiaLeukemia","type":{"media":"Online-Ressource","bibl":"periodical"}}],"origin":[{"dateIssuedDisp":"29 July 2004","dateIssuedKey":"2004"}]} | ||
| SRT | |a BUESCHEGUNTREATMENTI2920 | ||